Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Debled

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary TumorsClément Morgat, Gaétan MacGrogan, Véronique Brouste, et al.
Cardiovascular and Interventional Radiology|July 18, 2015
Single-Centre Experience with Percutaneous Cryoablation of Breast Cancer in 23 Consecutive Non-surgical PatientsRoberto Luigi Cazzato, Christine Tunon de Lara, Xavier Buy, et al.
Cancer|June 22, 2010
Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?Florence Ragage, Marc Debled, Gaëtan MacGrogan, et al.
The Journal of Pathology. Clinical Research|April 2, 2024
The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular featuresHélène Salaün, Lounes Djerroudi, Laura Haik, et al.
Radiology|June 14, 2012
Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomesJean Palussière, Corinne Henriques, Louis Mauriac, et al.
Breast (Edinburgh, Scotland)|December 31, 2023
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life dataYasmine Rhanine, Hervé Bonnefoi, Anthony Goncalves, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2015
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitudeMarc Debled, Gaëtan MacGrogan, Christelle Breton-Callu, et al.
Breast Cancer Research and Treatment|September 19, 2019
Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapyClémence Pinard, Marc Debled, Houda Ben Rejeb, et al.
Springerplus|September 26, 2015
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteriaIsabelle de Mascarel, Marc Debled, Véronique Brouste, et al.
The Oncologist|July 4, 2013
Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancersMartine Boisserie-Lacroix, Gaëtan Macgrogan, Marc Debled, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary TumorsClément Morgat, Gaétan MacGrogan, Véronique Brouste, et al.
Cardiovascular and Interventional Radiology|July 18, 2015
Single-Centre Experience with Percutaneous Cryoablation of Breast Cancer in 23 Consecutive Non-surgical PatientsRoberto Luigi Cazzato, Christine Tunon de Lara, Xavier Buy, et al.
Cancer|June 22, 2010
Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?Florence Ragage, Marc Debled, Gaëtan MacGrogan, et al.
The Journal of Pathology. Clinical Research|April 2, 2024
The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular featuresHélène Salaün, Lounes Djerroudi, Laura Haik, et al.
Radiology|June 14, 2012
Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomesJean Palussière, Corinne Henriques, Louis Mauriac, et al.
Breast (Edinburgh, Scotland)|December 31, 2023
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life dataYasmine Rhanine, Hervé Bonnefoi, Anthony Goncalves, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2015
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitudeMarc Debled, Gaëtan MacGrogan, Christelle Breton-Callu, et al.
Breast Cancer Research and Treatment|September 19, 2019
Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapyClémence Pinard, Marc Debled, Houda Ben Rejeb, et al.
Springerplus|September 26, 2015
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteriaIsabelle de Mascarel, Marc Debled, Véronique Brouste, et al.
The Oncologist|July 4, 2013
Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancersMartine Boisserie-Lacroix, Gaëtan Macgrogan, Marc Debled, et al.
Pageof 10